Tissue Plasminogen ActivatorPlasminogen Activator Inhibitor 1Urokinase-Type Plasminogen ActivatorPlasminogen ActivatorsPlasminogenStrokeFibrinolysisFibrinolytic AgentsPlasminogen InactivatorsThrombolytic TherapyFibrinolysinReceptors, Urokinase Plasminogen ActivatorFibrinBrain IschemiaPlasminogen Activator Inhibitor 2Cerebral HemorrhageStreptokinasealpha-2-AntiplasminRecombinant ProteinsAnnexin A2Intracranial ThrombosisFibrinogenTime FactorsInjections, IntravenousTreatment OutcomeHemostasisThrombosisInfarction, Middle Cerebral ArteryIntracranial HemorrhagesAcute DiseaseFibrin Fibrinogen Degradation ProductsIntracranial EmbolismBlood CoagulationCerebrovascular DisordersReperfusionInfusions, IntravenousCarboxypeptidase BHeparinCerebral InfarctionRetinal HemorrhageSerpin E2National Institute of Neurological Disorders and StrokeIsoflurophateReceptors, Cell SurfaceIntracranial Embolism and ThrombosisKringlesCells, CulturedEndothelium, VascularProspective StudiesThrombinSerine Proteinase InhibitorsAminocaproic AcidCarotid Artery ThrombosisUltrasonic TherapyCarboxypeptidase UKineticsRNA, MessengerInfusions, Intra-ArterialHemorrhageInjections, Intra-ArterialDose-Response Relationship, DrugTomography, X-Ray ComputedAntifibrinolytic AgentsVitronectinMolecular Sequence DataRisk FactorsUmbilical VeinsMyocardial InfarctionThrombectomyBrainBlood Coagulation FactorsDisease Models, AnimalBrain InfarctionUltrasonography, Doppler, TranscranialSeverity of Illness IndexMatrix Metalloproteinase 9GlycoproteinsSerpinsvon Willebrand FactorDrug Therapy, CombinationElectrophoresis, Polyacrylamide GelAnticoagulantsAmino Acid SequenceThrombomodulinRecovery of FunctionCell LineClot RetractionProtein BindingMice, Inbred C57BLCerebral AngiographyIschemic Attack, TransientPredictive Value of TestsNeuroprotective AgentsAntithrombin IIIRetrospective StudiesPeptide FragmentsRabbitsEnzyme-Linked Immunosorbent AssayCerebral ArteriesBinding Sites